New SARS-CoV-2 Variants — Clinical, Public Health, and Vaccine Implications

Cited by (561)

Items 301–400 of 561

1. Severe Acute Respiratory Syndrome Coronavirus-2 Inactivation Activity of the Polyphenol-Rich Tea Leaf Extract with Concentrated Theaflavins and Other Virucidal Catechins
   Yohei Takeda, Kyohei Tamura, Dulamjav Jamsransuren, Sachiko Matsuda, Haruko K. Ogawa · 2021 · Molecules
2. Imidazoles and benzimidazoles as putative inhibitors of SARS-CoV-2 B.1.1.7 (Alpha) and P.1 (Gamma) variant spike glycoproteins: A computational approach
   Vidyasrilekha Yele, Bharat Kumar Reddy Sanapalli, Afzal Azam. Mohammed · 2021 · Chemical Papers
3. Potential zoonotic spillover at the human–animal interface: A mini-review
   Ima Fauziah, Herjuno Ari Nugroho, Nova Dilla Yanthi, Rida Tiffarent, Sugiyono Saputra · 2024 · Veterinary World
4. SARS-CoV-2 Variant Tracking and Mitigation During In-Person Learning at a Midwestern University in the 2020-2021 School Year
   Carolina Avendaño, Aaron Lilienfeld, Liz Rulli, Melissa Stephens, Wendy Alvarez Barrios, Joseph Sarro, Michael E. Pfrender, Marie Lynn Miranda · 2022 · JAMA Network Open
5. Public understanding of science: Communicating in the midst of a pandemic
   S. Abdool Karim · 2022 · Public Understanding of Science
6. Analysis of the mutation dynamics of SARS-CoV-2 genome in the samples from Georgia State of the United States
   Waqas Ahmad, Sarfraz Ahmad, Riyaz M. Basha · 2022 · Gene
7. SARS-CoV-2 epidemiology, kinetics, and evolution: A narrative review
   Samuel Alizon, Mircea T. Sofonea · 2025 · Virulence
8. Differences in the organization of interface residues tunes the stability of the SARS-CoV-2 spike-ACE2 complex
   Mattia Miotto, Lorenzo Di Rienzo, Greta Grassmann, Fausta Desantis, Gianluca Cidonio, Giorgio Gosti, Marco Leonetti, Giancarlo Ruocco, Edoardo Milanetti · 2023 · Frontiers in Molecular Biosciences
9. A recombinant Mycobacterium smegmatis -based surface display system for developing the T cell-based COVID-19 vaccine
   Ziyu Wen, Cuiting Fang, Xinglai Liu, Yan Liu, Minchao Li, Yue Yuan, Zirong Han, Congcong Wang, Tianyu Zhang, Caijun Sun · 2023 · Human Vaccines & Immunotherapeutics
10. Jumping a Moving Train: SARS-CoV-2 Evolution in Real Time
    Ahmed M. Moustafa, Paul Joseph Planet · 2021 · Journal of the Pediatric Infectious Diseases Society
11. Ethics review of COVID-19 human challenge studies: A joint HRA/WHO workshop
    Eloise Williams, Kathrine J. Craig, Christopher Chiu, Hugh T Davies, Stephanie Ellis, Claudia Emerson, Euzebiusz Jamrozik, Monica L Jefford, Gagandeep Kang, Melissa C. Kapulu et al. · 2022 · Vaccine
12. Antibody–nanobody combination increases their neutralizing activity against SARS-CoV-2 and nanobody H11-H4 is effective against Alpha, Kappa and Delta variants
    Hung Van Nguyen, Mai Suan Li · 2022 · Scientific Reports
13. RASCL: Rapid Assessment of Selection in CLades through molecular sequence analysis
    Alexander G. Lucaci, Jordan D. Zehr, Stephen D. Shank, Dave Bouvier, Alexander Ostrovsky, Mei Han, Anton Nekrutenko, Darren Patrick Martin, Sergei L. Kosakovsky Pond · 2022 · PLoS ONE
14. Mesenchymal Stem Cell-Based COVID-19 Therapy: Bioengineering Perspectives
    Nihal Karakaş, Süleyman Üçüncüoğlu, Damla Uludağ, Birnur Sinem Karaoglan, Khalid Shah, Gürkan Öztürk · 2022 · Cells
15. Live virus neutralization testing in convalescent patients and subjects vaccinated against 19A, 20B, 20I/501Y.V1 and 20H/501Y.V2 isolates of SARS-CoV-2
    Carla Saade, Claudia González, Antonin Bal, Martine Valette, Kahina Saker, Bruno Lina, Laurence Josset, Mary‐Anne Trabaud, Guillaume Thiéry, Élisabeth Botelho-Nevers et al. · 2021 · Emerging Microbes & Infections
16. Non-anticoagulant heparin derivatives for COVID-19 treatment
    M. Cao, Meng Qiao, Muhammad Sohail · 2022 · International Journal of Biological Macromolecules
17. Amino acids 484 and 494 of SARS-CoV-2 spike are hotspots of immune evasion affecting antibody but not ACE2 binding
    Marta Alenquer, Filipe Ferreira, Diana Lousa, Mariana Valério, Mónica Medina-Lopes, Marie‐Louise Bergman, Juliana Gonçalves, Jocelyne Demengeot, Ricardo B. Leite, Jingtao Lilue et al. · 2021 · bioRxiv (Cold Spring Harbor Laboratory)
18. ACE2-Fc and DPP4-Fc decoy receptors against SARS-CoV-2 and MERS-CoV variants: a quick therapeutic option for current and future coronaviruses outbreaks
    Mohamed A. Alfaleh, Reem M. Alsulaiman, Sarah A. Almahboub, Leena Nezamuldeen, Ayat Zawawi, Najwa D. Aljehani, Muhammad Yasir, Rwaa Hussin Abdulal, Rami K Alkhaldi, Assala Helal et al. · 2023 · Antibody Therapeutics
19. Postanesthesia complications in pediatric patients with previous SARS‐CoV ‐2 infection: A cohort study
    Giuliana Geng‐Ramos, Jonathan Nelson, Angela C. Lee, Nina Deutsch, Chaitanya K. Challa, Sophie R. Pestieau, Md. Sohel Rana, Mark Hubbard, Jessica A. Cronin · 2022 · Pediatric Anesthesia
20. Laboratory and field evaluation of the STANDARD Q and Panbio™ SARS-CoV-2 antigen rapid test in Namibia using nasopharyngeal samples
    Iyaloo Konstantinus, Douglas Chiwara, Emmy‐Else Ndevaetela et al. · 2021 · medRxiv
21. Outbreak of SARS-CoV-2 Lineage 20I/501Y.V1 in a Nursing Home Underlines the Crucial Role of Vaccination in Both Residents and Staff
    Andrea Orsi, Alexander Domnich, Vanessa De Pace, Valentina Ricucci, Patrizia Caligiuri, Livio Bottiglieri, Rosanna Vagge, Maurizio Cavalleri, Francesco Orlandini, Bianca Marisa Bruzzone et al. · 2021 · Vaccines
22. Hotspots for mutations in the SARS-CoV-2 spike glycoprotein: a correspondence analysis
    Mohammad Reza Rahbar, Abolfazl Jahangiri, Saeed Khalili, Mahboubeh Zarei, Kamran Mehrabani-Zeinabad, Bahman Khalesi, Navid Pourzardosht, Anahita Hessami, Navid Nezafat, Saman Sadraei et al. · 2021 · Scientific Reports
23. Insights into the structure and dynamics of SARS-CoV-2 spike glycoprotein double mutant L452R-E484Q
    Shahzaib Ahamad, Kanipakam Hema, Shahnawaz Ahmad, Vijay Kumar, Dinesh Kumar Gupta · 2022 · 3 Biotech
24. Effect of Pfizer/BioNTech and Oxford/AstraZeneca vaccines against COVID-19 morbidity and mortality in real-world settings at countrywide vaccination campaign in Saudi Arabia.
    S. Meo, F. Fahad Al-Jassir, S. Al-Qahtani · 2021 · European Review for Medical and Pharmacological Sciences
25. SARS-CoV-2 variant-specific differences in inhibiting the effects of the PKR-activated integrated stress response
    Wanda Christ, Jonas Klingström, Janne Tynell · 2023 · Virus Research
26. COVID-19 Vaccine Hesitancy: The Perils of Peddling Science by Social Media and the Lay Press
    Shabeer Ali Thorakkattil, Suhaj Abdulsalim, Mohammed Salim Karattuthodi, Mazhuvanchery Kesavan Unnikrishnan, Muhammed Rashid, Girish Thunga · 2022 · Vaccines
27. Characteristics and outcomes of COVID-19 patients during the BA.5 omicron wave in Tehran, Iran: a prospective observational study
    M. Salehi, Arezoo Salami Khaneshan, Abbas Shakoori Farahani et al. · 2023 · BMC Infectious Diseases
28. Epidemiological and clinical characteristics of vaccinated COVID-19 patients: A meta-analysis and systematic review
    Wen Tian, Xingxiang Ren, Mei Han, Yuanyuan Zhang, Xu Gao, Zhihai Chen, Wei Zhang · 2022 · International Journal of Immunopathology and Pharmacology
29. The turning point of COVID‐19 severity is associated with a unique circulating neutrophil gene signature
    Carlos Alessandro Fuzo, Thais Fernanda de Campos Fraga‐Silva, Sandra Regina Maruyama, Víctor Alexandre Félix Bastos, Luana Aparecida Rogerio, Nayore Tamie Takamiya, Pedro Vieira Da Silva-Neto, Vinícius E. Pimentel, Diana Mota Toro, Malena M. Pérez et al. · 2023 · Immunology
30. Benchmark datasets for SARS-CoV-2 surveillance bioinformatics
    Lingzi Xiaoli, Jill V. Hagey, Daniel J. Park, Christopher A. Gulvik, Erin L. Young, Nabil-Fareed Alikhan, Adrian Lawsin, Norman Hassell, Kristen M. Knipe, Kelly F. Oakeson et al. · 2022 · PeerJ
31. The Emergence of the New P.4 Lineage of SARS-CoV-2 With Spike L452R Mutation in Brazil
    Cíntia Bittar, Fábio Sossai Possebon, Leila Sabrina Ullmann, Dayla Bott Geraldini, Vivaldo Gomes da Costa, Luiz Gonzaga Paula de Almeida, Paulo Ricardo da Silva Sanches, Nailton M. Nascimento-Júnior, Eduardo Maffud Cilli, Cecília Ártico Banho et al. · 2021 · Frontiers in Public Health
32. Spike Mutation Profiles Associated With SARS-CoV-2 Breakthrough Infections in Delta Emerging and Predominant Time Periods in British Columbia, Canada
    Chad D. Fibke, Yayuk Joffres, John R. Tyson, Caroline Colijn, Naveed Zafar Janjua, Christopher D. Fjell, Natalie Prystajecky, Agatha N. Jassem, Hind Sbihi · 2022 · Frontiers in Public Health
33. Identification of Potential SARS-CoV-2 CD8+ T Cell Escape Mutants
    Syed Faraz Ahmed, Muhammad Saqib Sohail, Ahmed Abdul Quadeer, Matthew R. McKay · 2022 · Vaccines
34. Automatic Analysis of Isothermal Amplification via Impedance Time-Constant-Domain Spectroscopy: A SARS-CoV-2 Case Study
    Roberto Giovanni Ramírez-Chavarría, Elizabeth Castillo-Villanueva, Bryan E. Alvarez-Serna, Julián Carrillo‐Reyes, Lizeth Torres, Rosa-María Ramírez-Zamora, Germán Buitrón, Luis A. Álvarez-Icaza · 2023 · Chemosensors
35. Variantes del SARS-CoV-2: epidemiología, fisiopatología y la importancia de las vacunas
    Marcelo Bedoya-Sommerkamp, Jesús Medina-Ranilla, Victor Hugo Chau Rodriguez, Renato Li-Soldevilla, Álvaro Vera-Albújar, Patricia Jannet Garcia · 2021 · Revista Peruana de Medicina Experimental y Salud Pública
36. Design, immunogenicity and efficacy of a Pan-SARS-CoV-2 synthetic DNA vaccine
    Charles C. Reed, Katherine Schultheis, Viviane M. Andrade, Richa Kalia, Jared Tur, Blake Schouest, Dustin Elwood, Jewell N. Walters, Igor Maricic, Arthur Doan et al. · 2021 · bioRxiv (Cold Spring Harbor Laboratory)
37. Pandemic strategies with computational and structural biology against COVID-19: A retrospective
    Ching‐Hsuan Liu, Cheng-Hua Lu, Liang Lin · 2021 · Computational and Structural Biotechnology Journal
38. COVID-19 as the leading cause of hospital deaths in the Brazilian public health system in 2020
    I. Zimmermann, M. Sanchez, L. C. Alves · 2021 · International Journal of Infectious Diseases
39. The causal effect of physical activity intensity on COVID-19 susceptibility, hospitalization, and severity: Evidence from a mendelian randomization study
    Xing Zhang, Xinyue Zhang, Siyuan Feng, Hansen Li · 2023 · Frontiers in Physiology
40. Rapid relaxation of pandemic restrictions after vaccine rollout favors growth of SARS-CoV-2 variants: A model-based analysis
    Debra Van Egeren, Madison Stoddard, Alexander Novokhodko, Michael S. Rogers, Diane Joseph‐McCarthy, Bruce R. Zetter, Arijit Chakravarty · 2021 · PLoS ONE
41. Dynamical changes of SARS‐CoV ‐2 spike variants in the highly immunogenic regions impact the viral antibodies escaping
    Lorenzo Di Rienzo, Mattia Miotto, Fausta Desantis, Greta Grassmann, Giancarlo Ruocco, Edoardo Milanetti · 2023 · Proteins Structure Function and Bioinformatics
42. Scope of SARS-CoV-2 variants, mutations, and vaccine technologies
    J. Wambani, P. Okoth · 2022 · The Egyptian Journal of Internal Medicine
43. The emergence of SARS-CoV-2 variants of concern is driven by acceleration of the evolutionary rate
    JohnS. H. Tay, Ashleigh F. Porter, Wytamma Wirth · 2021 · medRxiv
44. Is diffusion of SARS-CoV-2 variants of concern associated with different symptoms?
    2021 · Journal of Infection
45. Hair and nail manifestations of COVID‐19
    A. Tammaro, G. Adebanjo, Francesca Romana Parisella · 2022 · Journal of Cosmetic Dermatology
46. Potent 3CLpro inhibitors effective against SARS-CoV-2 and MERS-CoV in animal models by therapeutic treatment
    Peng-Fei Li, Yunjeong Kim, Chamandi S. Dampalla, Harry Nhat Nguyen, D. Meyerholz, David K. Johnson, Scott Lovell, W. Groutas, S. Perlman, Kyeong-Ok Chang · 2023 · mBio
47. Early Emergence Phase of SARS-CoV-2 Delta Variant in Florida, US
    Eleonora Cella, Sobur Ali, Sarah E. Schmedes, Brittany Rife Magalis, Simone Marini, Marco Salemi, Jason L. Blanton, Taj Azarian · 2022 · Viruses
48. Induction of Broadly Cross-Reactive Antibody Responses to SARS-CoV-2 Variants by S1 Nanoparticle Vaccines
    Cong Sun, Runyu Yuan, Chu Xie, Jiufeng Sun, Xin‐Yan Fang, Yisha Hu, Xiaohui Yu, Zheng Liu, Mu‐Sheng Zeng, Yinfeng Kang · 2022 · Journal of Virology
49. Air–Oxygen Blenders for Mechanical Ventilators: A Literature Review
    Gabryel F. Soares, O. M. Almeida, José Menezes · 2022 · Italian National Conference on Sensors
50. A review of epidemiology, clinical features and disease course, transmission dynamics, and neutralization efficacy of SARS-CoV-2 variants
    Paroma Deb, Md. Maruf Ahmed Molla, KM Saif‐Ur‐Rahman, Manik Chandra Das, Debashish Das · 2021 · Egyptian Journal of Bronchology
51. Optimization of 2-Aminoquinazolin-4-(3H)-one Derivatives as Potent Inhibitors of SARS-CoV-2: Improved Synthesis and Pharmacokinetic Properties
    Y. Shin, Jun-Young Lee, Sangeun Jeon et al. · 2022 · Pharmaceuticals
52. Interplay between receptor binding, immune escape and protein stability determines the natural selection of SARS-CoV-2 variants
    V. Upadhyay, A. Lucas, Sudipta Panja, Ryuki Miyauchi, Krishna M. G. Mallela · 2021
53. Sisonke phase 3B open-label study: Lessons learnt for national and global vaccination scale-up during epidemics
    Ameena Ebrahim Goga, Linda‐Gail Bekker, Nigel Garrett, Simbarashe G. Takuva, Ian Sanne, Right to Care, Johannesburg, South Africa, Jackline A. Odhiambo, Fatima Mayat, Lara Rosemary Fairall, Zameer Brey et al. · 2022 · South African Medical Journal
54. Delta SARS-CoV-2 inactivation and bactericidal performance of cotton wipes decorated with TiO2/Ag nanoparticles like Brazilian heavy-fruited Myrciaria cauliflora
    D. D. da Silva, A. Duran, A. Cabral, F. Fonseca, Rodrigo F. Bueno, Shu-Hui Wang, D. Rosa · 2022 · Materials Today Communications
55. Effectiveness of the Inactivated SARS-CoV-2 (Vero Cell) Vaccine in Peruvian Health Workers
    María Edith Solís-Castro, Alex Jaramillo-Corrales, Rommell Veintimilla Gonzalez Seminario, Noemi Janampa Grados, Idania Edith Mamani Pilco, Karina Elizabeth Vargas Quispe, Lenin La Torre, Mario Neyser Vásquez Dominguez, David Enriquez Cusi, Percy Minaya et al. · 2022 · Life
56. Waning neutralizing antibodies through 180 days after homologous and heterologous boosters of inactivated COVID-19 vaccine
    Zhifei Chen, Fangqin Xie, Hairong Zhang, Li Dong, Suhan Zhang, Mengping Zhang, Junrong Li, Jianfeng Xie, Lina Zhang, Xiuhui Yang et al. · 2025 · Frontiers in Public Health
57. Ongoing asthma management in children during the COVID-19 pandemic: to step down or not to step down?
    E. Abrams, S. Szefler · 2021 · The Lancet Respiratory Medicine
58. Terpenoid phytocompounds from mangrove plant Xylocarpus moluccensis as possible inhibitors against SARS-CoV-2: In silico strategy
    Kiran Bharat Lokhande, Arti Kale, Bhagyashree Shahakar, Ashish Shrivastava, Neelu N Nawani, K. Venkateswara Swamy, Ashutosh Singh, Sarika Pawar · 2023 · Computational Biology and Chemistry
59. Decoding SARS-CoV-2 variants: Mutations, viral stability, and breakthroughs in vaccines and therapies
    Zainularifeen Abduljaleel · 2025 · Biophysical Chemistry
60. A recombinant subunit vaccine candidate produced in plants elicits neutralizing antibodies against SARS-CoV-2 variants in macaques
    Narach Khorattanakulchai, Kanjana Srisutthisamphan, Balamurugan Shanmugaraj, Suwimon Manopwisedjaroen, Kaewta Rattanapisit, Chalisa Panapitakkul, Taratorn Kemthong, Nutchanat Suttisan, Suchinda Malaivijitnond, Arunee Thitithanyanont et al. · 2022 · Frontiers in Plant Science
61. Vaccination with a bacterial peptide conjugated to SARS-CoV-2 receptor-binding domain accelerates immunity and protects against COVID-19
    Athanasios Blanas, Haiko Karsjens, Aafke de Ligt, Elisabeth J. M. Huijbers, Karlijn van Loon, Stepan S. Denisov, Canan Durukan, Diederik J. M. Engbersen, Jan Groen, Sven Hennig et al. · 2022 · iScience
62. Public Health Response Measures for COVID-19 in Kazakhstan
    Zhamilya Battakova, Б.С. Имашева, Т.И. Слажнева, Marat Imashev, Vyacheslav Beloussov, Massimo N. Pignatelli, Aigerim Tursynkhan, Albert Askarov, Shynar Abdrakhmanova, Assel Adayeva et al. · 2023 · Disaster Medicine and Public Health Preparedness
63. Inhibition of SARS-CoV-2 Viral Channel Activity Using FDA-Approved Channel Modulators Independent of Variants
    Han‐Gang Yu, Gina Sizemore, Iván Martínez, Peter L. Perrotta · 2022 · Biomolecules
64. Changing Dynamics of SARS-CoV-2: A Global Challenge
    Ananya Chugh, Nimisha Khurana, Kangna Verma, Ishita Sehgal, Rajan Rolta, Pranjal Vats, Rajendra Phartyal, Deeksha Salaria, Neha Kaushik, Eun Ha Choi et al. · 2022 · Applied Sciences
65. New Monoclonal Antibodies Specific for Different Epitopes of the Spike Protein of SARS-CoV-2 and Its Major Variants: Additional Tools for a More Specific COVID-19 Diagnosis
    Sabrina Mariotti, Maria Vincenza Chiantore, Raffaela Teloni, Angelo Iacobino, Antonio Capocefalo, Zuleika Michelini, Martina Borghi, Melissa Baggieri, Antonella Marchi, Paola Bucci et al. · 2023 · Biomedicines
66. COVID-19: The Vaccine Race Continues
    L. Hayley Burgess, Carley Castelein, A. García Rubio, Mandelin K. Cooper · 2021 · HCA Healthcare Journal of Medicine
67. Opening up safely: public health system requirements for ongoing COVID-19 management based on evaluation of Australia’s surveillance system performance
    K. Lokuge, K. D'Onise, E. Banks · 2021 · BMC Medicine
68. COVID-19, Influenza, and Other Acute Respiratory Viral Infections: Etiology, Immunopathogenesis, Diagnosis, and Treatment. Part I. COVID-19 and Influenza
    T. N. Ilyicheva, Netesov Sv, Vadim Nikolaevich Gureyev · 2022 · Molecular Genetics Microbiology and Virology
69. Evaluating Data Sharing of SARS-CoV-2 Genomes for Molecular Epidemiology across the COVID-19 Pandemic
    Teresa Rito, Pedro Fernandes, Raquel Duarte, Pedro A. Soares · 2023 · Viruses
70. To be remembered: B cell memory response against SARS‐CoV ‐2 and its variants in vaccinated and unvaccinated individuals
    Nafees Ahmed, Atharv Athavale, Ankita Harishchandra Tripathi, Adarsh Subramaniam, Santosh Kumar Upadhyay, Anil Kumar Pandey, Ramesh Chandra Rai, Amit Awasthi · 2023 · Scandinavian Journal of Immunology
71. Transmission dynamics of SARS-CoV-2 variants in the Brazilian state of Pará
    Catarina Torres Pinho, Amanda Ferreira Vidal, Tatianne da Costa Negri, Renato R. M. Oliveira, Maria Clara da Costa Barros, Laura Closset, Jhully Azevedo dos Santos Pinheiro, Cíntia Braga-da-Silva, Caio Santos Silva, Leandro Lopes de Magalhães et al. · 2023 · Frontiers in Public Health
72. Humoral and Cellular Immune Response Elicited by the BNT162b2 COVID-19 Vaccine Booster in Elderly
    Daniela Dalla Gasperina, Giovanni Veronesi, Carlo Maria Castelletti, Stefania Varchetta, Sabrina Ottolini, Dalila Mele, Giuseppe Ferrari, Amruth K B Shaik, Fabrizio Celesti, Francesco Dentali et al. · 2023 · International Journal of Molecular Sciences
73. The protective immunity induced by SARS-CoV-2 infection and vaccination: a critical appraisal
    Eduardo Tosta · 2021 · Exploration of Immunology
74. Early referring saved lives in kidney transplant recipients with COVID-19: a beneficial role of telemedicine
    I. Zahradka, Vojtech Petr, Katarina Jakubov · 2023 · Frontiers in Medicine
75. Clinical Evaluation of In-House-Produced 3D-Printed Nasopharyngeal Swabs for COVID-19 Testing
    S. Grandjean Lapierre, S. Bedwani, F. Deblois et al. · 2021 · medRxiv
76. VH3-53/66-Class RBD-Specific Human Monoclonal Antibody iB20 Displays Cross-Neutralizing Activity against Emerging SARS-CoV-2 Lineages
    Кулемзин Сергей Викторович, Maria V. Sergeeva, Konstantin O. Baranov, Andrey A. Gorchakov, Sergey V. Guselnikov, Беловежец Татьяна Николаевна, Olga Yu. Volkova, Alexander M. Najakshin, Nikolai A. Chikaev, Daria Danilenko et al. · 2022 · Journal of Personalized Medicine
77. SARS-CoV-2 Spike mutations modify the interaction between virus Spike and human ACE2 receptors
    Pushpendra Mani Mishra, Farhan Anjum, Vladimir Nikolaevich Uversky, Chayan Kanti Nandi · 2022 · Biochemical and Biophysical Research Communications
78. Coding-Complete Genome Sequences of 11 SARS-CoV-2 B.1.1.7 and B.1.351 Variants from Metro Manila, Philippines
    John Mark Velasco, Piyawan Chinnawirotpisan, Maria Theresa Valderama, Khajohn Joonlasak, Wudtichai Manasatienkij, Angkana T. Huang, Paula Corazon Diones, Fatima Claire Navarro, Vicente Vila, Henry Tabinas et al. · 2021 · Microbiology Resource Announcements
79. Effectivity Analysis of COVID-19 Vaccines Against Emerging Variants of SARS-CoV-2
    Umar Saeed, Zahra Zahid Piracha, Hafsa Ashraf, Saba Tasneem, Sara Rizwan Uppal, Tabinda Islam, Maheen Fatima, A. Abid, R. Uppal, R. Uppal · 2022 · Archives of Clinical and Biomedical Research
80. Multiple thermocycles followed by LAMP with only two primers for ultrasensitive colorimetric viral RNA testing and tracking at single-base resolution.
    Peng-Bo Zhang, Ke Qin, Kejian Gao · 2023 · Analytica Chimica Acta
81. 501Y.V2 spike protein resists the neutralizing antibody in atomistic simulations
    Sơn Tùng Ngô · 2022 · Computational Biology and Chemistry
82. Nano-based techniques: A revolutionary approach to prevent covid-19 and enhancing human awareness
    Annamalai Asaikkutti, Karuppaiya Vimala, Ezhumalai Dhineshkumar, Praseeja Cheruparambath, Kaviarasu Balakrishnan, Venkatesan Arul · 2023 · Journal of Drug Delivery Science and Technology
83. Outcome of COVID19 in Patients With Osteogenesis Imperfecta: A Retrospective Multicenter Study in Saudi Arabia
    A. Alshukairi, Hazem Doar, A. Al-Sagheir et al. · 2022 · Frontiers in Endocrinology
84. A Comparative Analysis of SARS-CoV-2 Variants of Concern (VOC) Spike Proteins Interacting with hACE2 Enzyme
    Jia-Wei Chen, Ling-Tao Chen, Heng Quan, Soon Goo Lee, Kaniz Fatama Khan, Ying Xie, Qiao-Mu Li, Maria Valero, Z. Dai, Yi-Xin Xie · 2024 · International Journal of Molecular Sciences
85. In silico investigations of heparin binding to SARS‐CoV‐2 variants with a focus at the RBD/ACE2 interface
    Nemat Ali, Rehan Khan, Abdullah F. Alasmari, Vijay Kumar · 2022 · Process Biochemistry
86. Amantadine-assembled nanostimulator enhances dimeric RBD antigen-elicited cross-neutralization against SARS-CoV-2 strains
    Ye Zhang, Ruixin Wang, Chunyan He, Yufang Zhang, Zhongrui Luo, Jia Luo, Sisi Chen, Yu Jin, Bowen Xie, Ye Liu · 2022 · Nano Today
87. Community-based Case Studies of Vaccine Hesitancy and the COVID-19 Response in South Africa; The VaxScenes Study
    C. Wiysonge, N. Coulson, N. Pillay et al. · 2022 · medRxiv
88. An intranasally administrated SARS-CoV-2 beta variant subunit booster vaccine prevents beta variant viral replication in rhesus macaques
    Y. Sui, Jianping Li, H. Andersen et al. · 2021 · bioRxiv
89. Immunogenic SARS-CoV2 Epitopes Defined by Mass Spectrometry
    Ke Pan, Yulun Chiu, Eric L. Huang, Michelle M. Chen, Junmei Wang, Ivy P. Lai, Shailbala Singh, Rebecca Shaw, Michael J. MacCoss, Cassian Yee · 2021 · bioRxiv (Cold Spring Harbor Laboratory)
90. Proposal of a population wide genome-based testing for Covid-19
    Hans Rudolf Lehrach, Jon Curtis, Bodo M. H. Lange, Lesley Ann Ogilvie, Richard Gauss, Christoph Steininger, Erhard Scholz, Matthias Kreck · 2022 · Scientific Reports
91. CoVrimer: A tool for aligning SARS-CoV-2 primer sequences and selection of conserved/degenerate primers
    Merve Vural-Özdeniz, Aslinur Akturk, Mert Demirdizen, Ronaldo Leka, Rana Acar, Özlen Konu · 2021 · Genomics
92. Global control of COVID-19: good vaccines may not suffice
    Javier Eslava-Schmalbach, Eric B. Rosero, Nathaly Garzón Orjuela · 2021 · Revista Panamericana de Salud Pública
93. Tracking Co-Occurrence of N501Y, P681R, and Other Key Mutations in SARS-CoV-2 Spike for Surveillance
    Carol M. Lee, Shruthi Mangalaganesh, Laurence O.W. Wilson, Michael J. Kuiper, Trevor W. Drew, Seshadri S. Vasan · 2022 · Zoonotic Diseases
94. Lessons From the Impact of the COVID-19 Pandemic at the National Cancer Institute
    Fatima Karzai, William L. Dahut · 2022 · The Cancer Journal
95. Bean Extract-Based Gargle for Efficient Diagnosis of Active COVID-19 Infection Using Rapid Antigen Tests
    Joseph Kwon, Euna Ko, Se-Young Cho et al. · 2022 · Microbiology spectrum
96. Focused Review: Insight and Updates on COVID-19 from Progress in Microbes and Molecular Biology
    Angel Yun-Kuan Thye, Jodi Woan‐Fei Law · 2023 · Progress In Microbes & Molecular Biology
97. Post-COVID-19: Time to Change Our Way of Life for a Better Future
    Roch Listz Maurice · 2024 · Epidemiologia
98. Application of nanomaterials against SARS-CoV-2: An emphasis on their usefulness against emerging variants of concern
    Reema Iqbal, Sadia Khan, Haroon Muhammad Ali, Maham Khan, Shahid Wahab, Tariq Khan · 2022 · Frontiers in Nanotechnology
99. Full-genome sequencing and mutation analysis of SARS-CoV-2 isolated from Makassar, South Sulawesi, Indonesia
    Muhammad Nasrum Massi, Rufika Shari Abidin, Abd‐ElAziem Farouk, Handayani Halik, Gita Vita Soraya, Najdah Hidayah, Rizalinda Sjahril, Irda Handayani, Mohamad Saifudin Hakim, Faris Muhammad Gazali et al. · 2022 · PeerJ
100. Severe Acute Respiratory Syndrome- Coronavirus 2
     Maria H. Sjögren · 2021 · Anales de la Facultad de Medicina